COVID-19 Vaccine Development Tools Market size was valued at US$ 20.67 Bn in 2022 and the total revenue is expected to grow at 8.7% through 2022 to 2029, reaching nearly US$ 37.07 Bn.COVID-19 Vaccine Development Tools Market Overview:
Vaccine development tools are used for qualitative and quantitative analysis in order to obtain precise results. There are various technologies used as tools in vaccine development such as polymerase Chain reactions, Next generations sequencing, cell culture, Nucleic acid isolations and purifications, and various others. Also, there are computational tools for modern vaccine development.To know about the Research Methodology :- Request Free Sample Report
COVID-19 Vaccine Development Tools Market Dynamics
Owing to the massive entrance of vaccine inventors and producers from across the world, the industry is likely to secure its speed shortly. The SARS-CoV-2 infection curve has only started to upland, particularly in industrialized nations, despite the rapid discovery and distribution of vaccines. In addition, SARS-COV-2 variants will emerge in 2022, necessitating re-testing of first-generation vaccine effectiveness, while present efforts are still focused on identifying the best vaccine rollout plan to manage the unprecedented global vaccination campaigns. The life sciences industry is focusing on developing long-term recovery for the SARS-COV-2 infection, prompting companies such as Thermo Fisher Scientific, Inc., Sartorius AG, Agilent Technologies, Hamilton Company, and Bio-Rad Laboratories, Inc. are likely to expand their COVID-19 vaccine development tool portfolio. The importance of artificial intelligence in the COVID-19 vaccine race, an increasing pool of alliances to accelerate vaccine development and clinical trials, and substantial financing initiatives by government and commercial groups are all helping to the expansion of this business. The current climate of expedited vaccine development and clinical testing has prompted vaccine developers and industry players to work together. BioNTech, for example, expanded its cooperation with Merck KGaA in February 2021 to meet the needed supply of tools and technology for vaccine development. The extension of the partnership agreement with Merck is a strategic move aimed at speeding up the development of the mRNA-based COVID-19 vaccine. Merck's life science business division is helping about 50 vaccine research initiatives across the world using its tools.Segment Analysis:
The laboratory technologies segment is supplementing the growth of the COVID-19 Vaccine Development Tools Market. In 2022, the laboratory technologies category held the largest market share, contributing to 95.3 % revenue. The use of laboratory technologies in vaccine research and development, such as PCR, cell culture, flow cytometry, and spectrometry, is estimated to boost the segment's supremacy through forecast timeframe. In 2022, PCR and qPCR are likely to offer the most sales to the laboratory technology category. The segment growth is responsible for the widespread use of PCR techniques in vaccination monitoring software and efficacy testing. The vaccine research segment is anticipated to adhere to the growth of the COVID-19 Vaccine Development Tools Market. In 2022, the vaccine research sector led the market, generating 44.2 % revenue. Several elements, like increased state financing, intensive research by universities and healthcare organizations, and greater business development strategies by significant pharmaceutical industries, are driving the segment's rise. Secondly, the segment's rise might be due to ongoing research initiatives aimed at enhancing the vaccine development process. For illustration, Stanford University scientists are working on the establishment of a new coronavirus vaccination that can be stored at room temperature in January 2021. This factor may potentially lower the cost of vaccine storage and shipment. Furthermore, corporations are actively pursuing COVID-19 target discoveries through commercial development tactics such as agreements, partnerships, and collaborations. Merck & Co., Inc. and the Institute for Systems Biology (ISB) confirmed a partnership in April 2021 to investigate and hit individuals for COVID-19 vaccine development. Scientists used a variety of approaches to examine blood samples, comprising proteomics, transcriptomics, metabolomics, and genetic tools, to measure the effects of infection and identify possible biomarkers for predicting the likelihood of severe illness. These findings were important for the formation of a COVID-19 vaccine.Regional Insights:
In 2022, North America had a revenue share of 28.0 %. Multiple reasons, including enhanced research and development efforts, funded initiatives, the presence of valuable players, rising COVID-19 cases, and a huge population base getting COVID-19 vaccination, among others, have contributed to the region's rise. Secondly, the market growth is attributable to the government's promotion of COVID-19 vaccine development efforts. The US government, for example, created Operation Warp Speed, a public-private collaboration to research, manufacture, and deploy COVID-19 vaccinations. Further, mergers and collaborations in American countries such as US. are predicted to lift the market growth in the forecast period. For example, Illumina, Inc., and Helix collaborated in January 2021 to create a nationwide surveillance infrastructure in the United States to track the emergence and prevalence rate of new SARS-CoV-2 strains. This integrates Helix's global COVID-19 testing infrastructure with Illumina's sequencing technology that helps the country's modern detection efforts discover and identify new SARS-CoV-2 variants. The objective of the report is to present a comprehensive analysis of the Global market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global market dynamics, structure by analyzing the market segments and project the Global market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global market make the report investor’s guide.COVID-19 Vaccine Development Tools Market Scope: Inquire before buying
COVID-19 Vaccine Development Tools Market Base Year 2022 Forecast Period 2023-2029 Historical Data CAGR Market Size in 2022 Market Size in 2029 2018 to 2022 8.7% US$ 20.67 Bn US$ 37.07 Bn Segments Covered by Technology Laboratory Technologies Next Generation Sequencing PCR & qPCR Flow Cytometry Spectrometry Microscopy & Electron Microscopy Preparative & Process Chromatography Nucleic Acid Isolation & Purification Transfection Electroporation Cell Culture Automated Liquid Handling Online Technologies Interactive Web Technologies Vaccine Management & Tracker Technologies by Application Vaccine Research Vaccine Process Development Vaccine Quality Assurance/Quality Control by End-User Pharma & Biopharma Companies Contract Research Organization (CROs) Academic & Research Institutes Regions Covered North America United States Canada Mexico Europe UK France Germany Italy Spain Sweden Austria Rest of Europe Asia Pacific China S Korea Japan India Australia Indonesia Malaysia Vietnam Taiwan Bangladesh Pakistan Rest of APAC Middle East and Africa South Africa GCC Egypt Nigeria Rest of ME&A South America Brazil Argentina Rest of South America Key Players
1. Thermo Fisher Scientific, Inc. 2. Celerion 3. Cole-Parmer Instrument Company, LLC. 4. Pfizer Inc. 5. Sartorius AG 6. STEMCELL Technologies Inc. 7. AB Sciex Pte. Ltd. 8. Illumina, Inc. 9. Agilent Technologies 10. Bio-Rad Laboratories, Inc. 11. Danaher 12. Merck KGaA 13. Qiagen N.V. 14. Shimadzu Corporation 15. Eurofins Scientific 16. Charles River Laboratories 17. Takara Bio Inc. 18. PerkinElmer Inc. 19. Fluidigm 20. OLYMPUS CORPORATION 21. Avantor, Inc. 22. Polyplus Transfection 23. Hamilton Company 24. Aurora Biomed Inc.FAQs:
1. What is the global COVID-19 Vaccine Development Tools market value in 2022? Ans: The global COVID-19 Vaccine Development Tools market value in 2022 was estimated as 20.67 Billion USD. 2. What is the global COVID-19 Vaccine Development Tools market growth? Ans: The global COVID-19 Vaccine Development Tools market is anticipated to grow with a CAGR of 8.7 % in the forecast period and is likely to reach USD 37.07 Billion by the end of 2029. 3. Which Application is expected to dominate the global COVID-19 Vaccine Development Tools market during the forecast period? Ans: The vaccine research segment dominated the market and accounted for the largest revenue share of 43.9% in 2022. 4. What are the factors driving the market? Ans: Key factors driving the market growth include the integral role of AI in the COVID-19 vaccine race, expanding pool of collaborations to fast-track vaccine research & clinical trials, and robust funding initiatives by government & private organizations. 5. Who are the key players in the global market? Ans: Some of the key players operating in the COVID-19 vaccine development tools market are Thermo Fisher Scientific, Inc.; Celerion; Cole-Parmer Instrument Company, LLC.; Pfizer Inc.; Sartorius AG; STEMCELL Technologies Inc.; AB Sciex Pte. Ltd.; Illumina, Inc.; Agilent Technologies; Bio-Rad Laboratories, Inc.; Danaher; Merck KGaA; Qiagen N.V.; Shimadzu Corporation; Eurofins Scientific; Charles River Laboratories; Takara Bio Inc.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Application 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Application 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Application 2.3.2. Primary Research 2.3.2.1. Data from Primary Application 2.3.2.2. Breakdown of Primary Application 3. Executive Summary: Global COVID-19 Vaccine Development Tools Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the COVID-19 Vaccine Development Tools Market 3.4. Geographical Snapshot of the COVID-19 Vaccine Development Tools Market, By Manufacturer share 4. Global COVID-19 Vaccine Development Tools Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global COVID-19 Vaccine Development Tools Market 5. Supply Side and Demand Side Indicators 6. Global COVID-19 Vaccine Development Tools Market Analysis and Forecast, 2022-2029 6.1. Global COVID-19 Vaccine Development Tools Market Size & Y-o-Y Growth Analysis. 7. Global COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 7.1.1. Laboratory Technologies 7.1.1.1. Next Generation Sequencing 7.1.1.2. PCR & qPCR 7.1.1.3. Flow Cytometry 7.1.1.4. Spectrometry 7.1.1.5. Microscopy & Electron Microscopy 7.1.1.6. Preparative & Process Chromatography 7.1.1.7. Nucleic Acid Isolation & Purification 7.1.1.8. Transfection Electroporation 7.1.1.9. Cell Culture 7.1.1.10. Automated Liquid Handling 7.1.2. Online Technologies 7.1.2.1. Interactive Web Technologies 7.1.2.2. Vaccine Management & Tracker Technologies 7.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 7.2.1. Vaccine Research 7.2.2. Vaccine Process Development 7.2.3. Vaccine Quality Assurance/Quality Control 7.3. Others Market Size (Value) Estimates & Forecast By End-User, 2022-2029 7.3.1. Pharma & Biopharma Companies 7.3.2. Contract Research Organization (CROs) 7.3.3. Academic & Research Institutes 8. Global COVID-19 Vaccine Development Tools Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 9.1.1. Laboratory Technologies 9.1.1.1. Next Generation Sequencing 9.1.1.2. PCR & qPCR 9.1.1.3. Flow Cytometry 9.1.1.4. Spectrometry 9.1.1.5. Microscopy & Electron Microscopy 9.1.1.6. Preparative & Process Chromatography 9.1.1.7. Nucleic Acid Isolation & Purification 9.1.1.8. Transfection Electroporation 9.1.1.9. Cell Culture 9.1.1.10. Automated Liquid Handling 9.1.2. Online Technologies 9.1.2.1. Interactive Web Technologies 9.1.2.2. Vaccine Management & Tracker Technologies 9.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 9.2.1. Vaccine Research 9.2.2. Vaccine Process Development 9.2.3. Vaccine Quality Assurance/Quality Control 9.3. Others Market Size (Value) Estimates & Forecast By End-User, 2022-2029 9.3.1. Pharma & Biopharma Companies 9.3.2. Contract Research Organization (CROs) 9.3.3. Academic & Research Institutes 10. North America COVID-19 Vaccine Development Tools Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 12. Canada COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 13. Mexico COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 14. Europe COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 15. Europe COVID-19 Vaccine Development Tools Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 17. France COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 18. Germany COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 19. Italy COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 20. Spain COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 21. Sweden COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 22. CIS Countries COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 23. Rest of Europe COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 24. Asia Pacific COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 25. Asia Pacific COVID-19 Vaccine Development Tools Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 27. India COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 28. Japan COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 29. South Korea COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 30. Australia COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 31. ASEAN COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 32. Rest of Asia Pacific COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 33. Middle East Africa COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 34. Middle East Africa COVID-19 Vaccine Development Tools Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 36. GCC Countries COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 37. Egypt COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 38. Nigeria COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 39. Rest of ME&A COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 40. South America COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 41. South America COVID-19 Vaccine Development Tools Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 43. Argentina COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 44. Rest of South America COVID-19 Vaccine Development Tools Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the COVID-19 Vaccine Development Tools Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Abbott Diabetes Care Inc 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Thermo Fisher Scientific, Inc. 45.3.3. Celerion 45.3.4. Cole-Parmer Instrument Company, LLC. 45.3.5. Pfizer Inc. 45.3.6. Sartorius AG 45.3.7. STEMCELL Technologies Inc. 45.3.8. AB Sciex Pte. Ltd. 45.3.9. Illumina, Inc. 45.3.10. Agilent Technologies 45.3.11. Bio-Rad Laboratories, Inc. 45.3.12. Danaher 45.3.13. Merck KGaA 45.3.14. Qiagen N.V. 45.3.15. Shimadzu Corporation 45.3.16. Eurofins Scientific 45.3.17. Charles River Laboratories 45.3.18. Takara Bio Inc. 45.3.19. PerkinElmer Inc. 45.3.20. Fluidigm 45.3.21. OLYMPUS CORPORATION 45.3.22. Avantor, Inc. 45.3.23. Polyplus Transfection 45.3.24. Hamilton Company 45.3.25. Aurora Biomed Inc. Primary Key Insights